Related Experiment Video
Updated: May 6, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Transfusion strategies for patients in pediatric intensive care units
Jacques Lacroix1, Paul C Hébert, James S Hutchison
1Université de Montréal, Montreal, Canada. jacques_lacroix@ssss.gouv.qc.ca
Insights
A restrictive red-cell transfusion strategy (hemoglobin threshold of 7 g/dL) in critically ill children is as safe as a liberal strategy (9.5 g/dL), significantly reducing transfusion needs without increasing adverse outcomes.
Area of Science:
- Pediatric critical care medicine
- Hematology
- Transfusion medicine
Background:
- Optimal hemoglobin thresholds for erythrocyte transfusions in critically ill children remain unclear.
- This study investigated a restrictive transfusion strategy using leukocyte-reduced packed red cells.
Purpose of the Study:
- To determine if a restrictive transfusion strategy (hemoglobin threshold of 7 g/dL) is non-inferior to a liberal strategy (9.5 g/dL) in stable, critically ill children.
- To assess safety outcomes, particularly multiple-organ dysfunction syndrome.
Main Methods:
- A noninferiority trial involving 637 stable, critically ill children with hemoglobin <9.5 g/dL.
- Random assignment to either a restrictive (7 g/dL) or liberal (9.5 g/dL) hemoglobin threshold for red-cell transfusion.
Main Results:
- The restrictive strategy group received 44% fewer transfusions, with 54% receiving none compared to 2% in the liberal group.
- New or progressive multiple-organ dysfunction syndrome occurred in 12% of patients in both groups (absolute risk reduction 0.4%).
- No significant differences in mortality or other adverse events were observed between groups.
Conclusions:
- A hemoglobin threshold of 7 g/dL for red-cell transfusion is safe and effective in stable, critically ill children.
- This restrictive strategy significantly decreases transfusion requirements without compromising patient safety.
- The findings support a more conservative approach to red blood cell transfusions in this population.
Background:
The optimal hemoglobin threshold for erythrocyte transfusions in critically ill children is unknown. We hypothesized that a restrictive transfusion strategy of using packed red cells that were leukocyte-reduced before storage would be as safe as a liberal transfusion strategy, as judged by the outcome of multiple-organ dysfunction.
Methods:
In this noninferiority trial, we enrolled 637 stable, critically ill children who had hemoglobin concentrations below 9.5 g per deciliter within 7 days after admission to an intensive care unit. We randomly assigned 320 patients to a hemoglobin threshold of 7 g per deciliter for red-cell transfusion (restrictive-strategy group) and 317 patients to a threshold of 9.5 g per deciliter (liberal-strategy group).
Results:
Hemoglobin concentrations were maintained at a mean (+/-SD) level that was 2.1+/-0.2 g per deciliter lower in the restrictive-strategy group than in the liberal-strategy group (lowest average levels, 8.7+/-0.4 and 10.8+/-0.5 g per deciliter, respectively; P<0.001). Patients in the restrictive-strategy group received 44% fewer transfusions; 174 patients (54%) in that group did not receive any transfusions, as compared with 7 patients (2%) in the liberal-strategy group (P<0.001). New or progressive multiple-organ dysfunction syndrome (the primary outcome) developed in 38 patients in the restrictive-strategy group, as compared with 39 in the liberal-strategy group (12% in both groups) (absolute risk reduction with the restrictive strategy, 0.4%; 95% confidence interval, -4.6 to 5.4). There were 14 deaths in each group within 28 days after randomization. No significant differences were found in other outcomes, including adverse events.
Conclusions:
In stable, critically ill children a hemoglobin threshold of 7 g per deciliter for red-cell transfusion can decrease transfusion requirements without increasing adverse outcomes. (Controlled-trials.com number, ISRCTN37246456 [controlled-trials.com].).
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant I: Introduction
Acute Kidney Injury V: Interprofessional Care